API labeling. For APIs manufactured, pre-validation for clinical products, is it required to include a statement limited for investigational use like what’s required for clinical products?
Section 19.2 states “labeling for APIs intended for use in clinical trials should be appropriately
controlled and should identify the material as being for investigational use”.
